Familial Amyloidotic Polyneuropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-03-28
Clinical Trial Update: The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant [Phase 2]
Phase 2 study evaluating Revusiran (ALN-TTRSC) in patients with TTR-mediated amyloidosis after liver transplant has completed with posted re…